Dorsey Wright & Associates Galapagos Nv Transaction History

Dorsey Wright & Associates

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$122.47 - $213.56 $4.17 Million - $7.28 Million	-34,082 Closed	0 $0
Q2 2020 Jul 23, 2020	SELL	$185.52 - $231.25 $535,967 - $668,081	-2,889 Reduced 7.81%	34,082 $6.82 Million
Q1 2020 Apr 20, 2020	SELL	$143.0 - $274.03 $923,780 - $1.77 Million	-6,460 Reduced 14.87%	36,971 $7.24 Million
Q4 2019 Jan 31, 2020	SELL	$146.12 - $215.82 $264,038 - $389,986	-1,807 Reduced 3.99%	43,431 $8.98 Million
Q3 2019 Oct 31, 2019	SELL	$130.44 - $187.64 $75,916 - $109,206	-582 Reduced 1.27%	45,238 $6.91 Million
Q2 2019 Jul 02, 2019	SELL	$111.45 - $128.93 $308,827 - $357,265	-2,771 Reduced 5.7%	45,820 $5.91 Million
Q1 2019 Apr 04, 2019	BUY	$89.61 - $117.78 $25,897 - $34,038	289 Added 0.6%	48,591 $5.72 Million
Q4 2018 Jan 07, 2019	SELL	$87.81 - $110.65 $1.53 Million - $1.93 Million	-17,442 Reduced 26.53%	48,302 $4.43 Million
Q3 2018 Oct 12, 2018	SELL	$90.63 - $120.22 $2.97 Million - $3.94 Million	-32,800 Reduced 33.28%	65,744 $7.39 Million
Q2 2018 Jul 06, 2018	BUY	$88.4 - $105.34 $723,642 - $862,313	8,186 Added 9.06%	98,544 $9.31 Million
Q1 2018 Apr 30, 2018	BUY	$94.51 - $120.23 $2.28 Million - $2.91 Million	24,171 Added 36.52%	90,358 $8.73 Million
Q4 2017 Feb 14, 2018	BUY	$84.48 - $104.02 $1.51 Million - $1.85 Million	17,830 Added 36.87%	66,187 $6.21 Million
Q3 2017 Nov 06, 2017	BUY	$73.17 - $103.47 $1.08 Million - $1.53 Million	14,788 Added 44.05%	48,357 $4.94 Million
Q2 2017 Aug 10, 2017	BUY	N/A	33,569	33,569 $1.15 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.76B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.